I think the reason we are seeing these increased reports of side effects (150 cases of self harm or suicidal ideation in the EU, which is a small number) is simply because more people are taking them and because people are mistaking the secondary effects of weight loss with the side effects of the drug
Not just for injury rehabilitation
Important safety considerations include: Pancreatitis risk : If you develop severe, persistent abdominal pain that may radiate to your back, with or without vomiting, stop taking the medication and seek urgent medical attention Gallbladder disease : Sudden pain in the upper right abdomen, fever, or yellowing of the skin/eyes requires urgent medical review GLP-1 medications are not recommended in people with severe gastrointestinal disease, including severe gastroparesis [10] [11] Clinical considerations include: Starting with the lowest available dose and titrating slowly Monitoring symptom patterns carefully during initiation Distinguishing between temporary side effects (which often lessen over weeks) and persistent symptom changes Adjusting dietary intake, particularly meal size and composition Most gastrointestinal side effects of GLP-1 medications are dose-dependent and tend to diminish over time as the body adapts
16 While food appears to decrease absorption, multiple studies have suggested that the volume of the water ingested with the tablet does not affect the location or effectivess of the tablet erosion
A health plan CEO recently said in the Washington Post, and he said about GLP-1 medications for obesity "Everybody intuitively believes these medications create long-term health benefits, but the evidence hasnt yet demonstrated that paying todays prices generates enough downstream savings, There are no brand-name drugs currently marked in the U.S.to treat chronic diseases which lower total medical expenses
